Toru Ishibashi
4PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jan 20, 2025
Safety, Tolerability, and Pharmacokinetics of a Novel Anti-obesity Agent, S-309309, in Healthy Adults with or Without Obesity.Toru Ishibashi, Hideki Tanioka, Tatsuya Ikehara
|Nov 20, 2024
Population Pharmacokinetics of Ensitrelvir in Healthy Participants and Participants with SARS-CoV-2 Infection in the SCORPIO-SR Study.Toru Ishibashi, Ryosuke Shimizu, Ryuji Kubota
|Apr 24, 2020
Clinical Drug-Drug Interaction Studies to Evaluate the Effects of a P-Glycoprotein Inhibitor, CYP3A Inhibitors, and a CYP3A Inducer on the Pharmacokinetics of Naldemedine in Healthy Subjects.Kazuya Fukumura, Nao Kawaguchi, Toru Ishibashi
|Jan 30, 2020
Carryover effects of baloxavir acid in human nasopharyngeal/pharyngeal swabs on infectious titer testing of influenza virus.Keiko Baba, Ryoko Oka, Shinya Shano
Pageof 1
Frequent Collaborators
2 joint publications
Ryuji Kubota
1 joint publications
Shinya Omoto
1 joint publications
Takao Shishido
1 joint publications
Kazuya Fukumura
1 joint publications
Nao Kawaguchi
1 joint publications
Yukio Tada
1 joint publications
Eriko Ogura
1 joint publications
Ryosuke Shimizu
1 joint publications
Hideki Tanioka
1 joint publications
Tatsuya Ikehara
